Tag: SNM therapy
US patent office rejects Axonics’ latest challenge to Medtronic patents
Medtronic has announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office has affirmed the validity of claims...
Axonics receives CE-mark approval for fourth-generation rechargeable SNM therapy
Axonics has announced that the Axonics R20 rechargeable sacral neuromodulation (SNM) system has received CE-mark approval.
Axonics expects to commence sales of the R20 to...
Axonics announces definitive agreement to be acquired by Boston Scientific
Axonics has announced that it has entered into a definitive agreement to be acquired by Boston Scientific Corporation for US$71 in cash per share,...
Neuspera completes patient enrolment and implants for SANS-UUI pivotal clinical trial
Neuspera Medical recently announced it has completed patient enrolment and implant procedures for the SANS-UUI pivotal clinical trial of its Neuspera system—a discreet, minimally...
Office-based removal of sacral neuromodulation devices deemed safe and well-tolerated
As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a...
Axonics receives US FDA approval for fourth-generation rechargeable sacral neuromodulation system
Axonics has announced that the US Food and Drug Administration has approved the company’s fourth-generation rechargeable sacral neuromodulation (SNM) system—a technology intended to provide...
Neuspera announces first successful Nuvella system implant in second phase of...
Neuspera Medical has announced the first patient has been successfully implanted with the Nuvella system in its pivotal SANS-UUI clinical trial, which will evaluate...
Axonics files FDA premarket approval supplement for fourth-generation rechargeable neurostimulator
Axonics has filed a premarket approval (PMA) supplement with the US Food and Drug Administration (FDA) for its fourth-generation rechargeable sacral neuromodulation (SNM) implantable...
Medtronic receives FDA approval for InterStim X system for bladder and...
Medtronic has announced receipt of approval from the US Food and Drug Administration (FDA) for its new, recharge-free InterStim system—with the device being made...
